Literature DB >> 24415299

Juvenile idiopathic arthritis patients and their skeletal status: possible role of vitamin D receptor gene polymorphism.

M M Kostik1, A M Smirnov, G S Demin, L A Scheplyagina, V I Larionova.   

Abstract

We evaluated bone mineralization and metabolism changes related to vitamin D receptor (VDR) polymorphic genotypes in children with juvenile idiopathic arthritis. One hundred and ninety eight children (82 boys and 116 girls) were included in our study. Bone mineral density (BMD) was measured by lumbar spine DXA. Osteocalcin, CTX, parathyroid hormone, total and ionized calcium, inorganic phosphate, total alkaline phosphatase activity was utilized for assessment of bone metabolism. Molecular testing: TaqI (rs731236) and Cdx2 (rs11568820) polymorphisms of VDR were detected by RFLP. No differences in TaqI and Cdx2 haplotypes, genotypes and alleles distribution related with normal and low BMD (Zscore <-2SD) were found. Children with low linear growth (<10th percentile) had more allele T-contained genotypes of TagI VDR (p = 0.037), compare with medium or high linear growth children. Children with high linear growth (>90th percentile) had the highest frequency of allele A-contained genotypes (GA+AA) of Cdx2 VDR (p = 0.009). Girls with TT TaqI VDR, who never been treated by glucocorticoides had lower BMD-Zscore than C allele carriers (TT = -0.94SD [IQR: -2.1;-0.5], TC+CC = -0.62SD [IQR: -1.26;0.39], p = 0.03). Girls with Tanner I with TT had higher total and ionized Ca level than carriers of C allele (Ca: TT = 2.43 ± 0.15 mmol/l, TC+CC = 2.28 ± 0.2 mmol/l, p = 0.024; Ca(2+): TT = 1.15 ± 0.08 mmol/l, TC+CC = 1.06 ± 0.13 mmol/l, p = 0.026). Presence of TT genotype negatively correlated with BMD-Zscore (r = -0.28, p = 0.04), and positively with frequency of LBMD (r = 0.3, p = 0.037). Boy with GG Cdx2 genotype had lower total Ca (GG = 2.3 ± 0.17 mmol/l, GA+AA = 2.43 ± 0.17 mmol/l, p = 0.004) compare with carriers of A allele. Pubertal boys (Tanner IV-V) with GG had higher CTX (GG = 1.75 ± 0.11 ng/ml, GA+AA = 1.06 ± 0.07 ng/ml, p = 0.04. TT genotype of TaqI and GG genotype of Cdx2 VDR is a negative factor impact bone mineralization metabolism and linear growth.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24415299     DOI: 10.1007/s11033-014-3040-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  27 in total

Review 1.  A review of asthma genetics: gene expression studies and recent candidates.

Authors:  Giovanni Malerba; Pier F Pignatti
Journal:  J Appl Genet       Date:  2005       Impact factor: 3.240

2.  The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine.

Authors:  H Yamamoto; K Miyamoto; B Li; Y Taketani; M Kitano; Y Inoue; K Morita; J W Pike; E Takeda
Journal:  J Bone Miner Res       Date:  1999-02       Impact factor: 6.741

3.  Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus.

Authors:  J I San-Pedro; J R Bilbao; G Perez de Nanclares; J C Vitoria; P Martul; L Castaño
Journal:  Autoimmunity       Date:  2005-09       Impact factor: 2.815

4.  Effects of vitamin D receptor gene polymorphisms on susceptibility to disease and bone mineral density in Turkish patients with type 1 diabetes mellitus.

Authors:  A Kocabaş; G Karagüzel; N Imir; U Yavuzer; S Akçurin
Journal:  J Pediatr Endocrinol Metab       Date:  2010-12       Impact factor: 1.634

5.  Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

6.  Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis.

Authors:  Laura Masi; Rolando Cimaz; Gabriele Simonini; Giuseppe Bindi; Stefano Stagi; Alessia Gozzini; Cecilia Malentacchi; Maria Luisa Brandi; Fernanda Falcini
Journal:  J Rheumatol       Date:  2002-10       Impact factor: 4.666

7.  Protection from type 1 diabetes by vitamin D receptor haplotypes.

Authors:  Elizabeth Ramos-Lopez; Thomas Jansen; Vytautas Ivaskevicius; Heinrich Kahles; Christian Klepzig; Johannes Oldenburg; Klaus Badenhoop
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

8.  Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients.

Authors:  B Goertz; W J Fassbender; J C Williams; A M Marzeion; R G Bretzel; H Stracke; M N Berliner
Journal:  Clin Exp Rheumatol       Date:  2003 May-Jun       Impact factor: 4.473

9.  Vitamin D receptor gene polymorphisms have negligible effect on human height.

Authors:  Stuart Macgregor; Jouke-Jan Hottenga; Penelope A Lind; H Eka D Suchiman; Gonneke Willemsen; P Eline Slagboom; Grant W Montgomery; Nicholas G Martin; Peter M Visscher; Dorret I Boomsma
Journal:  Twin Res Hum Genet       Date:  2008-10       Impact factor: 1.587

10.  Vitamin D and estrogen receptor-alpha genotype and indices of bone mass and bone turnover in Danish girls.

Authors:  Siobhan Cusack; Christian Mølgaard; Kim F Michaelsen; Jette Jakobsen; Christel J E Lamberg-Allardt; Kevin D Cashman
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.976

View more
  2 in total

1.  Study of vitamin D status and vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis.

Authors:  Francesca Marini; Fernanda Falcini; Stefano Stagi; Sergio Fabbri; Simone Ciuffi; Donato Rigante; Marco Matucci Cerinic; Maria Luisa Brandi
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

Review 2.  Vitamin D Supplementation in Patients with Juvenile Idiopathic Arthritis.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Shue-Fen Luo; Jing-Long Huang; Jenn-Haung Lai
Journal:  Nutrients       Date:  2022-04-07       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.